Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K231928
    Date Cleared
    2023-09-25

    (87 days)

    Product Code
    Regulation Number
    892.2050
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    EFAI RTSUITE CT HCAP-Segmentation System

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    EFAI HCAPSeg is a software device intended to assist trained radiation oncology professionals, including, but not limited to, radiation oncologists, medical physicists, and dosimetrists, during their clinical workflows of radiation therapy treatment planning by providing initial contours of organs at risk on non-contrast CT images. EFAI HCAPSeg is intended to be used on adult patients only.

    The contours are generated by deep-learning algorithms and then transferred to radiation therapy treatment planning systems. EFAI HCAPSeg must be used in conjunction with a DICOM-compliant treatment planning system to review and edit results generated. EFAI HCAPSeg is not intended to be used for decision making or to detect lesions.

    EFAI HCAPSeg is an adjunct tool and is not intended to replace a clinician's judgment and manual contouring of the normal organs on CT. Clinicians must not use the software generated output alone without review as the primary interpretation.

    Device Description

    EFAI RTSuite CT HCAP-Segmentation System, herein referred to as EFAI HCAPSeg, is a standalone software that is designed to be used by trained radiation oncology professionals to automatically delineate organs-at-risk (OARs) on CT images. This auto-contouring of OARs is intended to facilitate radiation therapy workflows.

    The device receives CT images in DICOM format as input and automatically generates the contours of OARs, which are stored in DICOM format and in RTSTRUCT modality. The device does not offer a user interface and must be used in conjunction with a DICOM-compliant treatment planning system to review and edit results. Once data is routed to EFAI HCAPSeg, the data will be processed and no user interaction is required, nor provided.

    The deployment environment is recommended to be in a local network with an existing hospital-grade IT system in place. EFAI HCAPSeg should be installed on a specialized server supporting deep learning processing. The configurations are only being operated by the manufacturer:

    • Local network setting of input and output destinations;
    • Presentation of labels and their color; ●
    • Processed image management and output (RTSTRUCT) file management. ●
    AI/ML Overview

    Here's a detailed breakdown of the acceptance criteria and the study that proves the device meets them, based on the provided text:

    Acceptance Criteria and Device Performance

    Acceptance Criteria CategorySpecific CriteriaReported Device Performance (EFAI HCAPSeg)Statistical Result (p-value)
    OARs Present in Both EFAI HCAPSeg and Comparison DeviceThe mean Dice Coefficient (DSC) of OARs for each body part (Head & Neck, Chest, Abdomen & Pelvis) should be non-inferior to that of the comparison device, with a pre-specified margin.Overall Mean DSC: 0.83 (vs. 0.75 for Head & Neck, 0.84 for Chest, 0.82 for Abdomen & Pelvis in comparison device)
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1